Setchell, K D R <br/><br/>
Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Mar 2005 
 - 709-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2005.02385.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bile--chemistry<br/>Bile Acids and Salts--blood<br/>Capsules<br/>Cholagogues and Choleretics--pharmacokinetics<br/>Chromatography, High Pressure Liquid--methods<br/>Cross-Over Studies<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Compliance<br/>Therapeutic Equivalency<br/>Ursodeoxycholic Acid--pharmacokinetics